Michael Triplett
Directeur Général chez Armatus Bio LLC
Profil
Michael Triplett was the founder of Myonexus Therapeutics, Inc. where he held the title of President, Chief Executive Officer & Director from 2017 to 2019.
He is also the founder of Armatus Bio LLC.
Currently, Dr. Triplett holds the position of Director at Andelyn Biosciences, Inc. and Trustee at BioOhio.
Postes actifs de Michael Triplett
| Sociétés | Poste | Début |
|---|---|---|
BioOhio
 BioOhio Miscellaneous Commercial ServicesCommercial Services BioOhio is a non-profit organization that connects and serves Ohio's bioscience community to drive success in improving the quality of life. The non-profit company is based in Columbus, OH. With over 300 member organizations that employ over 100,000 people, BioOhio provides member-guided services that include networking, advocacy, events, talent, information, and cost savings. BioOhio is the state affiliate for bioscience associations such as Advamed, Bio, PhRMA, and more. Eddie Pauline has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
Armatus Bio LLC
 Armatus Bio LLC BiotechnologyHealth Technology Armatus Bio, Inc. is a biotechnology company that operates at the intersection of genetic science and bioengineering. The company is based in Columbus, OH. The company was founded by Peter G. Kleinhenz, Michael Triplett. Michael Triplett has been the CEO since incorporation. | Directeur Général | - |
Andelyn Biosciences
 Andelyn Biosciences BiotechnologyHealth Technology Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Triplett
| Sociétés | Poste | Fin |
|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Fondateur | 01/04/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BioOhio
BioOhio Miscellaneous Commercial ServicesCommercial Services BioOhio is a non-profit organization that connects and serves Ohio's bioscience community to drive success in improving the quality of life. The non-profit company is based in Columbus, OH. With over 300 member organizations that employ over 100,000 people, BioOhio provides member-guided services that include networking, advocacy, events, talent, information, and cost savings. BioOhio is the state affiliate for bioscience associations such as Advamed, Bio, PhRMA, and more. Eddie Pauline has been the CEO of the company since 2021. | Commercial Services |
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
Andelyn Biosciences
Andelyn Biosciences BiotechnologyHealth Technology Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone. | Health Technology |
Armatus Bio LLC
Armatus Bio LLC BiotechnologyHealth Technology Armatus Bio, Inc. is a biotechnology company that operates at the intersection of genetic science and bioengineering. The company is based in Columbus, OH. The company was founded by Peter G. Kleinhenz, Michael Triplett. Michael Triplett has been the CEO since incorporation. | Health Technology |